Skip to main content

Posts

Showing posts from January 15, 2025

#USA, #California: Current #H5N1 #Influenza in #Human #Situation as of January 15 '25: One new case, total = 38

Current Bird Flu Situation Updated January 15, 2025​ --  ​​​​The current risk to the public remains low.  â€‹â€‹ -- No person-to-person spread of bird flu has been detected in California.  -- People rarely get bird flu , but those who interact​ with infected dairy cows, poultry, or wildlife ​have a greater risk of infection.​​ -- Pasteurized milk and dairy products are safe to consume. Pasteurization inactivates the bird flu virus.​​ -- CDPH is working to protect public health related to bird flu. We monitor infection data, evolving science, and the people affected. Our knowledge will change as we learn more. We are committed to reducing the impact to those at highest risk. Human Cases in Califo​rnia​ -- ​​​​​​​Confirmed Human Cases​ :  38 {+1} ​These numbers were last updated on January 15, 2025. California has 1 additional probable case with dairy cow exposure that meets the  Council of State and Territorial Epidemiologists (CSTE) ​probable case definiti...

#USA, US #CDC: #H5 #Birdflu #Response: Focus Areas for Ongoing Public Health #Risk #Assessment

{Edited} Current H5N1 bird flu risk People who are at increased risk include : -- Farmers and workers who work with infected animals or their byproducts -- Backyard bird flock owners -- Animal care workers (e.g., veterinarians, wild animal facility workers) -- Animal health and public health responders. But what factors would influence a change to CDC’s current risk assessment for the general public? What follows is a description of the epidemiological and virologic characteristics of the avian influenza situation that CDC scientists are tracking to formulate the agency’s immediate avian flu risk assessment and further calibrating the avian flu response to protect the public’s health: -- Virus transmission : How is virus spreading and how efficiently does it spread? -- Disease severity : How ill do people with H5N1 bird flu infections become? -- Case distribution: How widespread are cases? -- Effects of genetic changes in the virus : What is the impact of genetic changes to the virus o...

#USA, Confirmed #H5N1 #influenza #human case summary since 2024, by state and exposure source: 1 new case in CA, total now = 67

{Excerpt} Exposure Source [ State -  Exposure Associated with Commercial Agriculture and Related Operations: Dairy Herds (Cattle) - Poultry Farms and Culling Operations -- Other Animal Exposure† - Exposure Source Unknown‡ - State Total ] 1) California -  36 - 0 - 0 - 2 -  38 {+1} 2) Colorado -  1 - 9 - 0 - 0 -  10 3) Iowa -  0 - 1 - 0 - 0 -  1 4) Louisiana -  0 - 0 - 1 - 0 -  1 5) Michigan -  2 - 0 - 0 - 0 -  2 6) Missouri -  0 - 0 - 0 - 1 -  1 7) Oregon -  0 - 1 - 0 - 0 -  1 8) Texas -  1  - 0 - 0 - 0 -  1 9) Washington -  0 - 11 - 0 - 0 -  11 10) Wisconsin -  0 - 1 - 0 - 0 -  1 --  Source Total -  40 - 23 - 1 - 3 -  67 {+1} NOTE : One additional case was previously detected in a poultry w...

#Pathogenesis of #bovine #H5N1 clade 2.3.4.4b #infection in #Macaques

Abstract Since early 2022 highly pathogenic avian influenza (HPAI) H5N1 virus infections have been reported in wild aquatic birds and poultry throughout the United States (US) with spillover into several mammalian species 1-6. In March 2024, HPAIV H5N1 clade 2.3.4.4b was first detected in dairy cows in Texas , US and continues to circulate on dairy farms in multiple states7,8. Milk production and quality are diminished in infected dairy cows, with high virus titers in milk raising concerns of exposure to mammals including humans through consumption9-12. Here we investigated routes of infection with bovine HPAIV H5N1 clade 2.3.4.4b in cynomolgus macaques , a surrogate model for human infection13. We show that intranasal or intratracheal inoculation of macaques could cause systemic infection resulting in mild and severe respiratory disease , respectively. In contrast, infection by the orogastric route resulted in limited infection and seroconversion of macaques which remained subclinical...

Clinical #Features of #Human #Parvovirus B19-Associated #Encephalitis Identified in the #Dakar Region, #Senegal, and Viral Genome Characterization

Abstract Neurological manifestations associated with human parvovirus B19 (B19V) infections are rare and varied. Acute encephalitis and encephalopathy are the most common, accounting for 38.8% of all neurological manifestations associated with human B19V. Herein, we report on the clinical features of 13 laboratory-confirmed human cases of B19V-associated encephalitis in Senegal in the framework of a hospital-based surveillance of acute viral encephalitis conducted from 2021 to 2023. Overall, B19V was detected from 13 cerebrospinal fluid samples using specific real time PCR. The mean age was 16.7 years among B19V-positive patients, with a higher prevalence in 0–5-year-old children and the sex ratio (male/female) was 2.25. The B19V-positive patients mainly exhibited hypoleukocytosis, normal glycorrhachia, and normal proteinorrachia in the cerebrospinal fluid. While the main neurological symptoms included meningeal and infectious syndromes . Furthermore, three complete B19V genome sequenc...

Clade 2.3.4.4b but not historical clade 1 #HA replicating #RNA #vaccine protects against #bovine #H5N1 challenge in #mice

Abstract The ongoing circulation of influenza A H5N1 in the United States has raised concerns of a pandemic caused by highly pathogenic avian influenza. Although the United States has stockpiled and is prepared to produce millions of vaccine doses to address an H5N1 pandemic, currently circulating H5N1 viruses contain multiple mutations within the immunodominant head domain of hemagglutinin (HA) compared to the antigens used in stockpiled vaccines . It is unclear if these stockpiled vaccines will need to be updated to match the contemporary H5N1 strains. Here we show that a replicating RNA vaccine expressing the HA of an H5N1 isolated from a US dairy cow confers complete protection against homologous lethal challenge in mice. A repRNA encoding the HA of a clade 1 H5 from 2004 (A/Vietnam/1203/2004) as utilized by some stockpiled vaccines, confers only partial protection . Our data highlight the utility of nucleic acid vaccines to be rapidly updated to match emergent viruses of concern w...

GGCX promotes #Eurasian #avian-like #H1N1 #swine #influenza virus #adaption to interspecies #receptor binding

Abstract The Eurasian avian-like (EA) H1N1 swine influenza virus (SIV) possesses the capacity to instigate the next influenza pandemic , owing to its heightened affinity for the human-type α-2,6 sialic acid (SA) receptor . Nevertheless, the molecular mechanisms underlying the switch in receptor binding preferences of EA H1N1 SIV remain elusive. In this study, we conduct a comprehensive genome-wide CRISPR/Cas9 knockout screen utilizing EA H1N1 SIV in porcine kidney cells. Knocking out the enzyme gamma glutamyl carboxylase (GGCX) reduces virus replication in vitro and in vivo by inhibiting the carboxylation modification of viral haemagglutinin (HA) and the adhesion of progeny viruses, ultimately impeding the replication of EA H1N1 SIV. Furthermore, GGCX is revealed to be the determinant of the D225E substitution of EA H1N1 SIV, and GGCX-medicated carboxylation modification of HA 225E contributes to the receptor binding adaption of EA H1N1 SIV to the α-2,6 SA receptor. Taken together, our...

#Outbreak of suspected #Marburg Virus Disease - United Republic of #Tanzania

Description of the situation Introduction On 13 January 2025, WHO informed its Member States and IHR State Parties of an outbreak of suspected Marburg Virus Disease (MVD) in the Kagera region of the United Republic of Tanzania using our secure web-based platform—the Event Information Site (EIS). Under the International Health Regulations, the EIS is used to issue rapid alerts to Member States of acute and rapidly developing public health risks and events with possible international implications. Summary of the situation On 10 January 2025, WHO received reliable reports from in-country sources regarding suspected cases of MVD in the Kagera region of the United Republic of Tanzania. Six people were reported to have been affected , five of whom had died . The cases presented with similar symptoms of headache, high fever, back pain, diarrhoea, haematemesis (vomiting with blood), malaise (body weakness) and, at a later stage of disease, external haemorrhage (bleeding from orifices). As of 1...